Publications by authors named "Marc Hartmann"

Claim this Profile
S
Selective methylene oxidation in α,β-unsaturated carbonyl natural products.
Chiyoung Ahn, Alexander Gomez, Marc A Hartmann, M Christina White

Nature· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex all-comers and patients with diabetes and prediabetes treated with Xience Sierra everolimus-eluting stents: COASTLINE high-risk.
Daphne van Vliet, Eline H Ploumen, Tineke H Pinxterhuis, Rosaly A Buiten, Adel Aminian, Marc Hartmann

Eur Heart J Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease.
Tineke H Pinxterhuis, Eline H Ploumen, Marlies M Kok, Carl E Schotborgh, Rutger L Anthonio, Marc Hartmann

Cardiovasc Interv Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex and age-specific 10-year mortality after coronary stenting: an analysis of two randomized trials.
Tineke H Pinxterhuis, Eline H Ploumen, Carine J M Doggen, Daphne van Vliet, Marlies M Kok, Marc Hartmann

Eur Heart J Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials.
Eline H Ploumen, Edimir Semedo, Carine J M Doggen, Carl E Schotborgh, Rutger L Anthonio, Marc Hartmann

Neth Heart J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.
Tineke H Pinxterhuis, Eline H Ploumen, Daphne van Vliet, K Gert van Houwelingen, Martin G Stoel, Marc Hartmann

Atherosclerosis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents.
Tineke H Pinxterhuis, Eline H Ploumen, Carine J M Doggen, Marc Hartmann, Carl E Schotborgh

Eur Heart J Acute Cardiovasc Care· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of premature coronary artery disease on adverse event risk following percutaneous coronary intervention.
Tineke H Pinxterhuis, Eline H Ploumen, Paolo Zocca, Carine J M Doggen, Carl E Schotborgh, Marc Hartmann

Front Cardiovasc Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers.
Eline H Ploumen, Tineke H Pinxterhuis, Rosaly A Buiten, Paolo Zocca, Peter W Danse, Marc Hartmann

J Am Heart Assoc· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
Eline H Ploumen, Rosaly A Buiten, Paolo Zocca, Carine J M Doggen, Gillian A J Jessurun, Marc Hartmann

Catheter Cardiovasc Interv· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials.
Eline H Ploumen, Rosaly A Buiten, Marlies M Kok, Carine J M Doggen, Ariel Roguin, Marc Hartmann

Int J Cardiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary bifurcations treated with thin-strut drug-eluting stents: a prespecified analysis of the randomized BIO-RESORT trial.
Rosaly A Buiten, Sanne Warta, Eline H Ploumen, Carine J M Doggen, Liefke C van der Heijden, Marc Hartmann

Coron Artery Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.
Eline H Ploumen, Rosaly A Buiten, Carine J M Doggen, Martin G Stoel, K Gert van Houwelingen, Marc Hartmann

Am Heart J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
Eline H Ploumen, Rosaly A Buiten, Marlies M Kok, Carine J M Doggen, K Gert van Houwelingen, Marc Hartmann

Catheter Cardiovasc Interv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years.
Rosaly A Buiten, Eline H Ploumen, Paolo Zocca, Carine J M Doggen, Gillian A J Jessurun, Marc Hartmann

JACC Cardiovasc Interv· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nano-architectural complexity of zinc oxide nanowall hollow microspheres and their structural properties.
Katja Engelkemeier, Jörg K N Lindner, Julius Bürger, Kathrin Vaupel, Marc Hartmann

Nanotechnology· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.
Rosaly A Buiten, Eline H Ploumen, Paolo Zocca, Carine J M Doggen, Peter W Danse, Marc Hartmann

JACC Cardiovasc Interv· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial.
Paolo Zocca, Marlies M Kok, Liefke C van der Heijden, Peter W Danse, Carl E Schotborgh, Marc Hartmann

Cardiovasc Drugs Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population.
Marlies M Kok, Clemens von Birgelen, Naveed Sattar, Paolo Zocca, Marije M Löwik, Marc Hartmann

EuroIntervention· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial.
Marlies M Kok, Paolo Zocca, Rosaly A Buiten, Peter W Danse, Carl E Schotborgh, Marc Hartmann

EuroIntervention· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT.
Paolo Zocca, Marlies M Kok, Liefke C van der Heijden, K Gert van Houwelingen, Marc Hartmann

Int J Cardiol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial.
Clemens von Birgelen, Paolo Zocca, Rosaly A Buiten, Gillian A J Jessurun, Carl E Schotborgh, Marc Hartmann

Lancet· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
Clemens von Birgelen, Marlies M Kok, Naveed Sattar, Paolo Zocca, Cees Doelman, Marc Hartmann

JACC Cardiovasc Interv· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.
Paolo Zocca, Marlies M Kok, Kenneth Tandjung, Peter W Danse, Gillian A J Jessurun, Marc Hartmann

JACC Cardiovasc Interv· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.
Liefke C van der Heijden, Marlies M Kok, Paolo Zocca, Hanim Sen, Marije M Löwik, Marc Hartmann

J Am Heart Assoc· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis